IRIS
BASSET, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 827
EU - Europa 750
AS - Asia 388
SA - Sud America 36
AF - Africa 5
OC - Oceania 1
Totale 2.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 821
IE - Irlanda 313
CN - Cina 250
RU - Federazione Russa 141
FI - Finlandia 87
SG - Singapore 86
DE - Germania 78
IT - Italia 64
BR - Brasile 25
JP - Giappone 17
SE - Svezia 16
AT - Austria 9
IN - India 9
HK - Hong Kong 7
CA - Canada 5
CZ - Repubblica Ceca 5
GB - Regno Unito 5
BE - Belgio 4
LT - Lituania 4
NL - Olanda 4
CO - Colombia 3
ES - Italia 3
GR - Grecia 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CL - Cile 2
FR - Francia 2
IR - Iran 2
KR - Corea 2
LU - Lussemburgo 2
MU - Mauritius 2
PK - Pakistan 2
PL - Polonia 2
PT - Portogallo 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
SL - Sierra Leone 1
TH - Thailandia 1
TM - Turkmenistan 1
Totale 2.007
Salva come PNG Salva come JPEG
Città #
Dublin 311
Chandler 208
Ashburn 81
Helsinki 75
Singapore 59
Nanjing 54
Beijing 50
Boardman 48
Princeton 35
Shanghai 35
Lawrence 34
Medford 31
Wilmington 26
Pavia 24
Nanchang 20
Jacksonville 19
Moscow 17
Munich 17
Tokyo 16
Changsha 15
Shenyang 15
Hebei 14
Piscataway 13
Tianjin 11
Jiaxing 10
Los Angeles 10
Milan 10
New York 10
Falkenstein 9
Dallas 8
Nuremberg 8
Norwalk 7
Pune 7
Chicago 6
Hangzhou 6
Hong Kong 6
Tamm 6
Woodbridge 6
Fairfield 5
Redwood City 5
Seattle 5
Vienna 5
Brussels 4
Cagliari 4
Washington 4
Athens 3
Brno 3
Catania 3
London 3
Newark 3
Toronto 3
Baku 2
Bogotá 2
Dongdaemun-gu 2
Fuzhou 2
Houston 2
La Paz 2
Lisbon 2
Luxembourg 2
Ningbo 2
Palermo 2
Prague 2
Riyadh 2
Taizhou 2
Vinovo 2
Yerevan 2
Zhengzhou 2
Alessandria 1
Altoona 1
Amsterdam 1
Andover 1
Ann Arbor 1
Ashgabat 1
Asunción 1
Baltimore 1
Bandar Seri Begawan 1
Barbianello 1
Barra do Piraí 1
Belo Horizonte 1
Blumenau 1
Brasília 1
Buenos Aires 1
Cachoeiras de Macacu 1
Caetanos 1
Cairo 1
Campina Grande 1
Campinas 1
Cangzhou 1
Casablanca 1
Cervera del Rio Alhama 1
Clearwater 1
Clifton 1
Colombo 1
Como 1
Copenhagen 1
Cotia 1
Curitiba 1
Des Moines 1
Dubai 1
Fortaleza 1
Totale 1.452
Salva come PNG Salva come JPEG
Nome #
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis 75
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays 74
A patient with AL amyloidosis with negative free light chain results 65
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis 64
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response 62
Prognostication of survival and progression to dialysis in AA amyloidosis 60
Urinary albumin to creatinine ratio in diagnosis and risk stratification of renal AL amyloidosis 60
The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis 58
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 58
Patterns of relapse after upfront bortezomib therapy in AL amyloidosis 56
Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome 54
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis 54
Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies 53
Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis 52
Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcome 52
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosis 52
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate 49
A biomarker-based approach in management of AL amyloidosis: from risk assessment to tailored-treatment strategy 48
Daratumumab in light chain deposition disease: Rapid and profound hematologic response preserves kidney function 45
Growth Differentiation Factor 15 Is a New Biomarker for Survival and Renal Outcomes in Light Chain (AL) Amyloidosis 44
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: Prospective study in 206 patients 44
Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis 44
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy 44
Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis 44
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 44
The lung in amyloidosis 43
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosis 42
Single-molecule real-time sequencing of the M protein: Toward personalized medicine in monoclonal gammopathies 38
A complicated evaluation of the response to the therapy in a patient with light chain deposition disease 38
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: Results from a large cohort of patients 38
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis 36
A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis 36
A safety review of drug treatments for patients with systemic immunoglobulin light chain (AL) amyloidosis 35
Analysis of cyclin D1 mRNA expression levels in plasma cell dyscrasias: A systematic review of published literature 34
Clonal biomarkers for diagnosis and response to treatment assessment in light chain amyloidosis: The role of the laboratory 33
Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedside 32
A case of monoclonal gammopathy of renal significance 32
Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis 31
null 30
null 29
Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation 29
Free light measurement identifies relapse and prompts to reconsider amyloid typing in a patient with AL amyloidosis 27
Evaluation of response to treatment in a patient with light chain amyloidosis and low free light chain burden 24
Treatment of AL amyloidosis with bendamustine: A study of 122 patients 23
A Strategy for the Selection of RT-qPCR Reference Genes Based on Publicly Available Transcriptomic Datasets 21
Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patients 20
Development and Validation of Staging Systems for AA Amyloidosis 16
A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis 15
Early cardiac response is possible in stage IIIb cardiac AL amyloidosis and is associated with prolonged survival 11
Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis 11
Renal amyloidoses 11
Feasibility of a Biomarker-Based Screening for Pre-Symptomatic AL Amyloidosis in Patients With Intermediate/High-Risk MGUS 7
null 6
Totale 2.103
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.207
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060 0 0 0 0 0 0 0 0 1 28 14 17
2020/202168 8 0 2 3 1 5 3 17 25 2 0 2
2021/2022154 2 0 1 0 5 3 0 12 9 14 17 91
2022/2023698 59 62 11 31 46 56 13 35 351 3 21 10
2023/2024362 44 78 17 26 30 68 12 20 2 15 21 29
2024/2025521 27 57 9 28 10 75 79 35 201 0 0 0
Totale 2.103